MedNet

Research

The overarching goal for the research pillar is: Knowledge creation, translation, and exchange to gain insight and promote improved outcomes in patient and public health.

Read more about the objectives and draft outcomes, metrics, and activities for each below.


Objectives

R1: Create focused alignment with our partners to transform our leading research capabilities.

R2: Build powerful core platforms to support research and translation.

R3: Embed and extend patient-oriented clinical research capacity.

R4: Enhance our leadership in precision medicine across a population.

R5: Facilitate innovation, commercialization, and industry partnership and investment.

Draft Outcomes, Metrics, & Activities

R1: Create focused alignment with our partners* to transform** our leading research capabilities.

Outcomes & Outputs

  • Enhanced research competitiveness, excellence, and global leadership in transformation of health outcomes and care.
  • Increased alignment with partners through establishment of academic health systems (e.g.: AHSN and AHSCs).

Metrics

  • Amount of funding (grants, share of UBC’s tri-council, etc.) overall and related to clusters***.
  • Percentage of total grants awarded to collaborations (with PIs from different organizations).
  • Number of publications.
  • Number of projects in conjunction with HAs that relate to clusters.
  • Number of (or amount of revenue generated from) patents, licenses, and spin-offs.
  • Number of awards (prestigious national and international academic awards) received on areas of priority.
  • Consider qualitative impact metrics?

Activities

  • R1.1  Develop and launch Vancouver AHSC and a joint research office to oversee the execution of research governance and management. (Link w P1)
  • R1.2  Conduct an environmental scan to identify opportunities for collaboration around research priorities, platforms, and programs with other Faculties at UBC, with peer Faculties of Medicine, and with institutions along the Pacific Northwest corridor. Develop and implement a joint research strategy to pursue priority opportunities. (Link w P2)
  • R1.3  Develop a communication strategy for effective communication with stakeholders, highlighting research impact.

*Partners refers primarily to Health Authorities and the Centres which they oversee.

**Transformation refers to improvement in research and expansion of influence that come from aligning focus and resources

***Clusters refers to priorities (cancer, brain and mental health, heart and lung health, population health, chronic diseases) and themes (life sciences, life course and aging, prevention and complex disease management).

Back to top.

R2: Build powerful core platforms* to support research and translation.

Outcomes & Outputs

  • Ability to use the information from the platforms in research (research translation).
  • New cross-cutting platforms in place that integrate with core research infrastructure.
  • More effective allocation and utilization of research resources in the context of research priorities.

Metrics

  • Number of instances of research findings being implemented into clinical environments (e.g.: experimental access to a new test, changes to care guidelines, etc.). (TBC)
  • Number of new or improved platforms enabling improved or more efficient service.
  • Usage rates of new or improved platforms.
  • Metric for more effective allocation and utilization of resources?
  • Narrative impact of new platforms.
  • Percentage of platforms available at no cost

Activities

  • R2.1  Develop and implement strategy for allocation of resources based on priorities.
  • R2.2  Develop and implement plan for allocating resources to transform research capabilities (i.e.: CRC, CFI, JELF, EADR Endowments).
  • R2.3  Strengthen/build cross cutting platforms that are integrated with core research infrastructure supporting priorities and themes.
  • R2.4  Leverage existing UBC resources to develop and sustain effective internal infrastructure to support and coordinate new strategic grants/funding opportunities. Consult with VPR, UILO, etc.
  • R2.5  Develop and implement a philanthropic plan to support research priorities/platforms.
  • R2.6  Provide IT solutions and digital e-health to support research. Establish a working group.

*Platforms refers to tools and/or services with associated procedures and/or people that enable delivery.

Back to top.

R3: Embed and extend patient-oriented clinical research capacity.

Outcomes & Outputs

  • Strengthened patient-oriented, interdisciplinary, population-based clinical research.

Metrics

  • Number of patients participating in clinical trials.
  • Percentage of total research expenditure spent on clinical trials research.
  • Number of active trials per year.
  • Number of trials initiated per year involving interdisciplinary teams.
  • Distribution of research activity across phases of translational science (i.e.: phase 1-4 clinical studies).
  • Narrative impact of patient-oriented, interdisciplinary, population-based clinical research.
  • Extent to which UBC FoM is working in alignment with BC SPRO SUPPORT Unit.
  • Narrative impact of knowledge translation that involves integrated plans with patients/public.

Activities

  • R3.1  Increase engagement with BC SPOR SUPPORT Unit and SPOR National Networks to understand barriers to patient-oriented clinical research and obtain resources. Establish working forums that enable engagement, further collaboration and identify and address issues.
  • R3.2  Work with BC SPOR to implement patient-oriented research and strategies to overcome barriers.
  • R3.3  Create a working group with clinical investigators to identify funding avenues and hear from trainees about challenges and gaps regarding research needs, and leverage the group to advocate to the Provincial Government.

Back to top.

R4: Enhance our leadership in precision medicine across a population.

Outcomes & Outputs

  • Leadership in precision health* through increased presence of precision health in research and educational activities.

Metrics

  • Number of research initiatives related to precision health.
  • Percentage of grant and funding invested towards clinical, basic, and population research specific to precision health across the Faculty.
  • Number of students enrolling in graduate-level research in precision health.
  • Narrative impact of precision health focus in research and educational activities.

Activities

  • R4.1  Assess current research capacity and future needs in precision health and implement strategy for integration of precision health as a focus of research / research centres operating with a focus on precision health. Establish a process to review current activity in precision health and review market trends to determine future needs
  • R4.2  In collaboration with Education, develop and implement strategic plan to train learners in precision health.
  • R4.3  Engage with sector partners to develop and implement a plan to coordinate province-wide population-based studies. Establish forums among sector partners.

*Deliberately using health instead of medicine to encompass prevention as well as treatment.

Back to top.

R5: Facilitate innovation, commercialization, and industry partnership and investment.

Outcomes & Outputs

  • More innovation, commercialization, and industry partnership and investment.
  • Clear, effective path to commercialize innovation (incl. governance, compliance, and support).
  • Health and health care improvements from knowledge translation via industry partnership.

Metrics

  • Number of patents filed per year.
  • Number of ideas/findings/innovations that are commercialized (or make it to the commercialization stage) per year.
  • Number of ideas/findings/that are commercially successful.
  • Amount of investment from industry or number of collaborative initiatives with industry per year.
  • Narrative impact of innovation, commercialization, and industry partnership and investment.

Activities

  • R5.1  In collaboration with UBC existing resources, develop and implement a streamlined infrastructure to facilitate advancement and pursuit of innovation and commercialization. Policies, processes, and training.
  • R5.2  Develop and implement a cohesive strategy to support commercialization, knowledge mobilization and industry partnerships in conjunction with AHSC and PHIX.
  • R5.3  Coordinate with education and Entrepreneurship @ UBC to provide support and training to our learners and faculty members in the areas of commercialization and knowledge mobilization.
  • R5.4  Complete an environmental assessment of opportunities and potential industry partners, locally, nationally, and internationally. Develop and implement a way to pursue priority opportunities.

Back to top.